Press release
Ebola Drug and Vaccine Market - Global Industry Analysis 2016 - 2024
Ebola starts out as a sore throat, muscle pain, headache, and fever. It is a viral hemorrhagic fever, which means the patient bleeds internally as well as externally. The function of the liver and the kidneys is also hampered significantly by the Ebola virus. The lack of a reliable cure for Ebola is the primary driver for the global Ebola drug and vaccines market, with the need to come up with a solution being among the most urgent and financially among the most lucrative in the world.
Download exclusive Brochure of this report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=12476
The report examines the performance of the global Ebola drug and vaccines market through 2015 to provide a thorough review of the market’s historical performance. The market’s current conditions are presented in the report extensively and accurately. This provides the base for solid forecasts regarding the market’s likely dynamics in the coming years. The report assesses every aspect of the global Ebola drug and vaccines market, including its major segments, key players, and the drivers and restraints affecting the course of the market.
Global Ebola Drug and Vaccines Market: Drivers and Restraints
The major driver for the global Ebola drug and vaccines market is the lack of a foolproof solution at present. While containment and management protocols for Ebola have been developed, a cure has yet to be discovered. This prime unmet need is driving the global Ebola drug and vaccines market. Due to steady government support to Ebola research, developing Ebola drugs and vaccines has also become commercially lucrative for pharmaceutical companies. This is also expected to be a major driver for the market in the coming years.
View exclusive Global strategic Business report:
http://www.transparencymarketresearch.com/ebola-drug-and-vaccine-market.html
The unpredictable nature of Ebola has also helped spur research efforts, since the risk posed by a disease increases massively if its etiology and pathophysiology are not known.
An important non-medical factor having an influence on the global Ebola drug and vaccines market is the increasing number of people traveling between countries. In Western Africa, where Ebola is most common, the number of people emigrating to developed countries is quite high. This has increased the risk of an Ebola epidemic in countries such as the U.S. and the U.K. This factor will remain a major driver for the global Ebola drug and vaccines market in the coming years, as it has helped spread awareness about the disease in regions where long-term research into the disease is economically feasible.
Global Ebola Drug and Vaccines Market: Region-wise Outlook
North America accounted for the dominant share in the global Ebola drug and vaccines market in 2015. The advanced medical research scenario in the U.S. is the primary reason behind the region’s dominance in the global market.
The report also profiles the competitive landscape of the global Ebola drug and vaccines market to help readers formulate winning strategies based on the present market hierarchy. Key Ebola drug and vaccine players profiled in the report include Tekmira Pharmaceuticals, Serepata Therapeutics, Mapp Biopharmaceutical, NewLink Genetics Corp., and BioCryst Pharmaceutical Inc.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Ebola Drug and Vaccine Market - Global Industry Analysis 2016 - 2024 here
News-ID: 400625 • Views: …
More Releases from TMR – Research Reports
Power Line Communication Market to Present Highly Lucrative Opportunities for Ma …
Power Line Communication (PLC) is an emerging communication technology which enables data exchange over existing power cables. It uses power grids to communicate between two end-points. PLC technology allow users to control or retrieve data in a half-duplex manner. Furthermore, in this communication method, sender modulates the data, and injects in power cables which can be retrieved by de-modulation at the receiving end. PLC technology is widely used for home…
Wood Coatings Market - Roof coatings to Register High Demand | 2025
The global wood coatings market is choc-o-bloc with players and this has served to intensify the competition over the years. Product differentiation is a key tool leveraged by players to steal a march over their competitors. Key factors promoting growth in the market are the soaring construction activities across the globe and the increasing spending capacity of people which has stoked sales of furniture.
Another factor catalyzing growth in the global…
Welding Materials Market - Thriving Growth In Industrial Application Segments By …
The global welding materials market is growing on account of the thriving growth of application segments such as transportation, building and construction, marine, and automobiles. The growing urbanization in developing nations will drive the growth of this market. The increasing infrastructure development in Asia Pacific will also fuel the growth of the welding materials market. The technological advancements in the automobile industry will also aid the growth of this market.…
Intumescent Coatings Market Demand for Improved Fire Safety to Fuel Growth By 20 …
The global intumescent coatings market has remained moderately concentrated as nearly 45% of its overall share was held by three enterprises in 2015. These companies were Sherwin-Williams Co., PPG Industries Inc., and Nobel N.V., finds Transparency Market Research (TMR) in a new study. These companies, besides other prominent market players are continuously making efforts to expand their regional footprint by establishing new manufacturing units.
While expanding operations across emerging nations has…
More Releases for Ebola
Ebola Virus Vaccine Market 2022 | Detailed Report
The Ebola Virus Vaccine research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market's key players. Furthermore, the report offers insightful market data and information about the Ebola…
Ebola Vaccine Market Opportunity Analysis, 2018-2026
Ebola virus disease (EVD) causes viral hemorrhagic fever. It is a life threatening disease, which is spread to humans from animals. Direct contact with body fluids of infected person is one of largest causes of spread of this infection. Symptoms of Ebola disease include high fever, vomiting, sore throat, diarrhea, headache and muscular pain, and in few cases, internal or external bleeding. Although, there is no cure for Ebola virus…
Ebola Vaccine Market - Global Industry Insights, 2017-2025
Increasing number of Ebola cases in affected regions and new vaccine development for this are expected to be factors driving growth of the market
Increasing mortality rates due to Ebola is expected to be a major factor for growth of the market. According to World Health Organization, in January 2018, around 50% people infected with EVD, have died. African countries such as Siberia, Sierra Leone, Guinea, Democratic Republic of Congo, Senegal,…
Ebola Treatment Market Rugged Expansion Foreseen by 2024
Ebola viral infection was first observed in The Democratic Republic of Congo (named after a river called Zaire) in 1976. Ebola is a viral disease which frequently causes lethal haemorrhagic fever in humans. The harmful consequences of Ebola viral infection are that the viruses can be used as potential biological weapon. The symptoms of Ebola viral infection include sudden onset of fever, sore throat, headaches, extreme tiredness, vomiting, skin rash,…
Growing Trends in Ebola Drug and Vaccine Market
The rising threat of a global Ebola pandemic is the major driver for the global Ebola drug and vaccines market, according to a new report from Transparency Market Research. The report, titled ‘Ebola Drug and Vaccine Market - Global Industry Analysis, Size, Share, Growth, Trends & Forecasts 2016 – 2024,’ presents a solid outline of the historical development of the market, in addition to comprehensive information about the market’s present…
Ebola Virus Vaccine Market & Pipeline Insight
Ebola virus infection, which was previously called Ebola hemorrhagic fever was discovered in 1976. The infection caused due to ebola virus originates from four different strains of ebola virus. These viruses generally are known to affect non-human primates, and are transmitted from wild animals to the humans and among the latter, it is known to spread through human-to-human transmission. The natural hosts of ebola virus are Fruit bats, which…
